Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation

Affiliations

• ¹ Department of Molecular Medicine, Sapienza University of Rome, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.
• ² North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. Electronic address: daniele.focosi@gmail.com.
• ³ Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; Unit of Adverse Drug Reactions Monitoring, Pisa University Hospital, Pisa, Italy.
• ⁴ Scientific Department, Army Medical Center, Rome, Italy.
• ⁵ Department of Public Health and Infectious Diseases, Sapienza University Hospital "Policlinico Umberto I", Rome, Italy.